Speakers

Thomas Herndon is a member of the Scientific Review Staff in the Office of Therapeutic Biologics and Biosimilars (OTBB) at FDA. Prior to joining OTBB, he worked in the Office of New Drugs as a member of several divisions involved with the review of hematology and oncology products. He brings practical experience in patient care and a background conducting medical research to OTBB. He received his undergraduate degree from the University of California and his Doctor of Medicine degree from Loyola University Chicago. He completed fellowship training at the National Institutes of Health.